EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma

Kewei Song, Chenhui Ma, Baohong Gu, Bofang Wang, Huanhuan Ma, Xiaobo Deng, Hao Chen iD

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.15094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Kewei Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal cancer (EC) occupies the seventh spot of the most prevalent malignancy cancer ailments worldwide and the sixth leading cause of cancer‐related death. Esophageal squamous cell carcinoma (ESCC) is also the most predominant histological subtype of EC, and cisplatin (DDP) is commonly used as a first‐line chemotherapeutic drug for the late advanced stages of the disease. However, the emergence of drug resistance during clinical treatment possesses a significant challenge to the therapeutic success and patient outcomes. Collectively, the epithelial‐mesenchymal transformation (EMT) is a process in which transcription factors are induced to regulate the expression of epithelial and stromal markers to promote the differentiation of epithelial cells into stromal cells. Recent studies have demonstrated a close association between EMT and chemotherapy resistance in tumor cells, with concrete evidence of reciprocal reinforcement. Therefore, in this review, we elucidate the molecular mechanism underlying ESCC, shed light on the mechanisms driving DDP resistance, and provide insights into the intricate interplay between EMT and ESCC. We have aimed to provide some new hypotheses and perspectives that may address‐inform future therapeutic strategies for ESCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsHumansCisplatinEpithelial-Mesenchymal TransitionCell Line, TumorCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

cisplatindrug-resistanceepithelial-mesenchymal transformationesophageal squamous cell carcinomatumor

Substanzen

Cisplatin

Autor:innen und Institutionen

  • The Second Clinical Medical College, Lanzhou University, Lanzhou, China.
  • Department of Public Health, Jining No.1 People's Hospital, Jining, China.
  • Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, China.
  • Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou, China.

ORCID-Profile: Hao Chen

Zitieren

APA

Song, K., Ma, C., Gu, B., Wang, B., Ma, H., Deng, X., & Chen, H. (2023). Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15094

Vancouver

Song K, Ma C, Gu B, Wang B, Ma H, Deng X, et al. Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma. Thoracic Cancer. 2023. doi:10.1111/1759-7714.15094

BibTeX
@article{Song2023,
  author = {Song, Kewei and Ma, Chenhui and Gu, Baohong and Wang, Bofang and Ma, Huanhuan and Deng, Xiaobo and Chen, Hao},
  title = {Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.15094}
}
Kostenlos starten →